43 results
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
in the assessment of our internal control over financial reporting.
We may take advantage of these exemptions until the fifth anniversary of our initial public
424B5
TCRX
Tscan Therapeutics Inc
16 Apr 24
Prospectus supplement for primary offering
5:21pm
parachute arrangements not previously approved; and
an exemption from the auditor attestation requirement in the assessment of our internal control
424B5
yve84pjusg
26 May 23
Prospectus supplement for primary offering
8:12pm
424B5
lno2zauypi5eu
25 May 23
Prospectus supplement for primary offering
4:59pm
8-K
EX-99.1
87mg8zh78
17 May 23
Poster highlights Phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell transplantation
8:15am
8-K
EX-1.1
42craj3
16 May 23
Other Events
5:21pm
424B5
tk1b9bvjs6wx
16 May 23
Prospectus supplement for primary offering
5:19pm
S-3
EX-4.4
6cn8cclk
9 Nov 22
Shelf registration
7:53am